Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD9668 in symptomatic COPD patients receiving budesonide/formoterol
2009-014586-75Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing AZD9668 plus budesonide/formoterol with Placebo plus budesonide/formoterol (2 arms). Primary endpoint: Pre-bronchodilator FEV1. Started Sep 2009; status: completed.
02
Drugs
alvelestat
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2009-014586-75.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014586-75.